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Abstract 45 
Arthropod herbivores cause dramatic crop losses, and frequent pesticide use has led to 46 
widespread resistance in numerous species. One such species, the two-spotted spider mite, 47 
Tetranychus urticae, is an extreme generalist herbivore and a major worldwide crop pest with 48 
a history of rapidly developing resistance to acaricides. Mitochondrial Electron Transport 49 
Inhibitors of complex I (METI-Is) have been used extensively in the last 25 years to control T. 50 
urticae around the globe, and widespread resistance to each has been documented. METI-I 51 
resistance mechanisms in T. urticae are likely complex, as increased metabolism by 52 
cytochrome P450 monooxygenases as well as a target-site mutation have been linked with 53 
resistance.  54 
 To identify loci underlying resistance to the METI-I acaricides fenpyroximate, 55 
pyridaben and tebufenpyrad without prior hypotheses, we crossed a highly METI-I-resistant 56 
strain of T. urticae to a susceptible one, propagated many replicated populations over multiple 57 
generations with and without selection by each compound, and performed bulked segregant 58 
analysis genetic mapping. Our results showed that while the known H92R target-site mutation 59 
was associated with resistance to each compound, a genomic region that included cytochrome 60 
P450-reductase (CPR) was associated with resistance to pyridaben and tebufenpyrad. Within 61 
CPR, a single nonsynonymous variant distinguished the resistant strain from the sensitive 62 
one. Furthermore, a genomic region linked with tebufenpyrad resistance harbored a non-63 
canonical member of the nuclear hormone receptor 96 (NHR96) gene family. This NHR96 64 
gene does not encode a DNA-binding domain (DBD), an uncommon feature in arthropods, 65 
and belongs to an expanded family of 47 NHR96 proteins lacking DBDs in T. urticae. Our 66 
findings suggest that although cross-resistance to METI-Is involves known detoxification 67 
pathways, structural differences in METI-I acaricides have also resulted in resistance 68 
mechanisms that are compound-specific. 69 
  70 
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1) Introduction 71 
Agrochemicals that inhibit electron transport in the mitochondrial respiratory chain have been 72 
commonly and successfully used against phytophagous mites (Lümmen, 2007; Van Leeuwen 73 
et al., 2014). These compounds are referred to as Mitochondrial Electron Transport Inhibitors 74 
(METIs) and have been classified into groups depending on the site or complex they block. 75 
Four large transmembrane complexes (I-IV) mediate electron transport in the mitochondrial 76 
inner membrane via several redox reactions from NADPH and FADH2 to oxygen, which 77 
serves as the final electron acceptor. An outcome of these sequential redox reactions is the 78 
proton gradient that drives ATP synthesis by the F0F1 ATPase (complex V) (Karp, 2008). 79 
Classic METIs like quinolines, pyridinamines, pyrazoles and pyridazinones act on complex I, 80 
the proton translocating NADH: ubiquinone oxidoreductase. This is the largest and most 81 
complex multi-subunit structure of the respiratory chain, and is responsible for catalyzing the 82 
electron transfer from NADH to coenzyme Q10 (ubiquinone). These acaricides are referred to 83 
as METI site I or METI-Is, and belong to Insecticide Resistance Action Committee (IRAC) 84 
group 21 (Hollingworth et al., 1994; Hollingworth and Ahammadsahib, 1995; Wirth et al., 85 
2016). Although the specific binding sites for ubiquinone and inhibitors may not be identical 86 
(Fendel et al., 2008; Tocilescu et al., 2010), inhibition of complex I has been described for 87 
many structurally diverse compounds that are thought to interfere with ubiquinone reduction 88 
(Degli Esposti, 1998; Lümmen, 1998). Competition experiments have shown that 89 
hydrophobic inhibitors of complex I share a common binding domain with at least partially 90 
overlapping sites (Okun et al., 1999). Structural data on complex I, as well as biochemical 91 
studies (Schuler and Casida, 2001; Shiraishi et al., 2012), support the hypothesis that binding 92 
sites for both ubiquinone and inhibitors are comprised of the nuclear-encoded PSST and the 93 
49 kDa subunits of complex I (Fiedorczuk et al., 2016; Vinothkumar et al., 2014; Zickermann 94 
et al., 2015). The PSST subunit is the most likely carrier of iron-sulfur cluster N2, a proposed 95 
direct electron donor for the ubiquinone reduction (Duarte et al., 2002; Friedrich, 1998; 96 
Magnitsky et al., 2002). 97 
 Acaricide resistance develops via two main mechanisms: the pharmacokinetic 98 
mechanism, which is primarily caused by a decreased exposure due to quantitative or 99 
qualitative changes in major detoxification enzymes and transporters, and the 100 
pharmacodynamic mechanism, which involves a decrease in sensitivity due to changes in the 101 
acaricide’s target site (Feyereisen et al., 2015; Li et al., 2007; Van Leeuwen and Dermauw, 102 
2016). These mechanisms are driven by three types of genetic changes (Feyereisen, 2015): (1) 103 
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mutations that affect the coding sequences of the target gene or detoxification genes, (2) 104 
mutations that alter expression levels of target/detoxification genes by affecting cis or trans 105 
regulation, or (3) whole target/detoxification gene duplications or deletions. Combinations of 106 
these genetic mechanisms are also possible. For instance, point mutations in 107 
acetylcholinesterase that make an organism resistant to organophosphates also decrease the 108 
enzyme’s effectiveness, leading to gene duplications as a compensation mechanism (Kwon et 109 
al., 2010). 110 
Tetranychus urticae (Acari; Tetranychidae), the two-spotted spider mite, is a major 111 
crop pest that feeds on over 1000 plant species and has been found on every continent except 112 
Antarctica (Migeon et al., 2006-2018). T. urticae is notoriously resistant to acaricides and 113 
insecticides, with resistance to over 95 active compounds reported to date (Michigan State 114 
University, 2018; Van Leeuwen and Dermauw, 2016). Resistance to METI-Is in T. urticae 115 
was initially documented in the 1990s and has since become widespread (Cho et al., 1995; 116 
Devine et al., 2001; Herron and Rophail, 1998; Ozawa, 1994). METI-I resistance in the spider 117 
mite was first associated with increased cytochrome P450 (P450) activity by synergism and 118 
enzyme activity tests (Cho et al., 1995; Devine et al., 2001; Herron and Rophail, 1998; 119 
Ozawa, 1994; Van Pottelberge et al., 2009b), and based on genome-wide microarray gene 120 
expression data, a number of constitutively upregulated P450s were identified in METI-I 121 
resistant strains. Subsequent studies revealed that one of those upregulated P450s 122 
(CYP392A11) metabolized fenpyroximate – but not pyridaben or tebufenpyrad – to a non-123 
toxic metabolite when expressed in E. coli (Riga et al., 2015), suggesting that the enzymes 124 
involved in METI-I metabolism may vary depending on the acaricide involved. More 125 
recently, targeted sequencing and genetic analysis identified a variant in the T. urticae PSST 126 
homologue of complex I, H92R (Yarrowia lipolytica numbering; H110R in T. urticae), that 127 
appeared to significantly reduce sensitivity to fenpyroximate, pyridaben, and tebufenpyrad 128 
(Bajda et al., 2017). This mutation is currently the only known genetic change associated with 129 
resistance to METI-I compounds in T. urticae. Introgression into a sensitive strain, however, 130 
suggested that the mutation explained only a fraction of the total resistance phenotype (Bajda 131 
et al., 2017). Additional genetic changes underlying other METI-I resistance mechanisms 132 
have so far remained elusive.  133 
The two-spotted spider mite is a tractable organism for characterizing resistance 134 
mechanisms, as its haplodiploid breeding system (males are haploid while females are 135 
diploid) facilitates inbred line construction, its genome size is small (~90Mb), the generation 136 
time is as little as a week at optimal temperatures, and very large populations can be 137 
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propagated (Van Leeuwen and Dermauw, 2016). Bulked segregant analysis (BSA) 138 
approaches have been used with T. urticae to identify monogenic loci (Bryon et al., 2017; 139 
Demaeght et al., 2014; Van Leeuwen et al., 2012), and these methods were recently extended 140 
to successfully describe polygenic resistance to a lipid-synthesis inhibiting acaricide, 141 
spirodiclofen (Wybouw et al., 2019). For genetic mapping of resistance with BSA methods, a 142 
resistant parent is crossed with a sensitive one, and resultant populations are expanded and 143 
selected with the pesticide. In T. urticae, BSA studies have used multigenerational 144 
populations (which allow dense recombination to break apart haplotypes – a prerequisite for 145 
high-resolution mapping), with whole-genome sequencing of parents and derived populations 146 
to simultaneously genotype and detect allele frequency changes that identify causal loci (i.e., 147 
fixation or increases in the frequency of alleles contributed by the resistant parent).  148 
In this study, we adapted recent advances in BSA methods, and a chromosome-level 149 
assembly of the T. urticae genome (Wybouw et al., 2019), to comprehensively investigate the 150 
quantitative (polygenic) genetic architecture of resistance to the METI-I acaricides 151 
fenpyroximate, pyridaben and tebufenpyrad. To do so, we performed multiple rounds of 152 
acaricide selection on the offspring of a cross between a Belgian greenhouse strain of T. 153 
urticae (MR-VP) that exhibited high levels of resistance to these commonly used METI-Is 154 
(Van Pottelberge et al., 2009b), and the METI-I-sensitive strain Wasatch (Bryon et al., 2017). 155 
As assessed by whole-genome sequencing, multiple quantitative trait loci (QTL) for the three 156 
METI-I acaricides were identified, revealing a common target-site mutation and suggesting 157 
novel acaricide-specific resistance mechanisms. 158 
 159 
2) Materials and methods 160 
2.1) Acaricides 161 
The acaricides used in this study were commercial formulations (Fyto Vanhulle, Belgium) of 162 
fenpyroximate (Naja; 50 g a.i. L-1 SC), pyridaben (Sanmite; 150 g a.i. L-1 SC) and 163 
tebufenpyrad (Pyranica; 200 g a.i. L-1 SC).  164 
 165 
2.2) T. urticae strains 166 
The METI-I resistant strain MR-VP was originally collected in September 2005 from bean 167 
plants in a greenhouse at the National Botanical Garden (Brussels, Belgium) (Van Pottelberge 168 
et al., 2009b), which had a spray history of tebufenpyrad (Pyranica; 200 g a.i. L-1 SC) and 169 
pyridaben (Sanmite; 150 g a.i. L-1 SC); the strain has since been kept in the laboratory at a 170 
constant selection pressure of 1000 mg L-1 tebufenpyrad. The susceptible Wasatch strain was 171 
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originally collected from tomato (Solanum lycopersicum) in Salt Lake City, Utah, USA 172 
(Bryon et al., 2017), from a public garden where spraying with synthetic pesticides was 173 
prohibited. Both strains were mother-son inbred for six generations as previously described 174 
(Bryon et al., 2017; Van Petegem et al., 2018). Prior to the experiment, both T. urticae strains 175 
were maintained under laboratory conditions (25 °C, 60% RH and 16:8 L:D photoperiod) on 176 
detached bean leaves (Phaseolus vulgaris) resting on cotton pads in plastic boxes to prevent 177 
contamination. LC50 assays for strains MR-VP and Wasatch were performed as previously 178 
described (Van Leeuwen et al., 2004). For each acaricide, LC50 values, slopes and 95% 179 
confidence limits of the parental strains were estimated using Probit Analysis (PoloPlus 180 
version 2.0; LeOra Software, Berkeley, CA, USA). If 5000 mg L-1 did not cause 50% 181 
mortality, no further attempts were made to determine LC50. 182 
 183 
2.3) Experimental evolution set-up of METI-I resistance 184 
An F1 hybrid population was generated by crossing 22 one-day-old virgin adult females of the 185 
inbred Wasatch strain with a single young male of the inbred MR-VP strain. 332 virgin F1 186 
teliochrysalis females were collected in total and were backcrossed to 70 males of the 187 
Wasatch strain. Subsequently, approximately 500 F2 females were used for the inoculation of 188 
potted bean plants, and the resulting segregating bulk populations were kept in a climatic 189 
chamber (Panasonic MLR-352H-PE, Kadoma, Japan) at 28 °C with a photoperiod of 16:8 h 190 
light:dark for 4-5 generations to expand the population. To set up acaricide selection, 500 191 
individuals from the bulk population were transferred to control plants or those sprayed with 192 
50 mg L-1 of either fenpyroximate, pyridaben, or tebufenpyrad; ten replicates were set up for 193 
each of the four groups. Experimental evolution on whole bean plants took place in the 194 
greenhouse at 21 °C over a period of nine months (~25 generations). When the population 195 
size was large enough, mites from each treatment group were transferred to new plants with 196 
an increasing concentration of the respective acaricide over time. The concentrations varied 197 
depending on the acaricide and were empirically determined based on the efficacy of the 198 
previous round of selection. Selection was considered complete when no acaricide-related 199 
mortality was observed on beans sprayed until run-off with the final concentrations of 3500, 200 
1250, and 750 mg L-1, for fenpyroximate, pyridaben, and tebufenpyrad, respectively.  201 
 202 
2.4) METI-I resistance and adaptation assay 203 
Effectiveness of selection to the three acaricides was evaluated by performing toxicity 204 
bioassays as previously described (Van Leeuwen et al., 2004). Mites were grown on 205 
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unsprayed bean plants for two to four generations, depending on the population size, before 206 
conducting toxicity tests. To determine toxicity, approximately 30 gravid adult females were 207 
transferred to 9 cm2 square-cut leaf discs on wet cotton wool and then sprayed with 1 ml of 208 
fluid at 1 bar pressure with a Potter Spray Tower (Burkard Scientific, Uxbridge, UK) to 209 
obtain a homogenous spray film (deposit of 2 mg cm-2). Each of the ten replicates of the three 210 
acaricide-selected populations and the control populations were tested in four replicates at a 211 
discriminating concentration of 2500 mg L-1 of the relevant acaricide. The leaf disks were 212 
kept in a climatically controlled room at 25 °C, 60% RH with a 16:8 h light:dark photoperiod 213 
for 24 hours. Mites were scored as being alive if they could walk normally after being 214 
prodded with a camel’s hair brush. Survival percentages of the three acaricide-selected and 215 
control populations were analyzed separately using a generalized linear mixed model with a 216 
binomial distribution using the lme4 R-package version 1.1 (Bates et al., 2015). Here, 217 
selection regime was incorporated as a fixed effect in the linear model, while replicate was 218 
regarded as a random effect. 219 
 220 
2.5) RNA extraction and sequencing 221 
Total RNA was extracted from about 100 adult female mites from the inbred MR-VP strain 222 
using the RNeasy mini kit (Qiagen, Belgium) with five-fold biological replication. The 223 
quality and quantity of the total RNA was analyzed by a DeNovix DS-11 spectrophotometer 224 
(DeNovix, Wilmington, DE, USA) and by running an aliquot on a 1% agarose gel. Illumina 225 
libraries were constructed from the RNA samples with the TruSeq Stranded mRNA Library 226 
Preparation Kit with polyA selection (Illumina, San Diego, CA, USA), and the resulting 227 
libraries were sequenced on an Illumina HiSeq 2000 to generate strand-specific paired reads 228 
of 2 × 100 bp (library construction and sequencing was performed at Centro Nacional de 229 
Análisis Genómico [CNAG], Barcelona, Spain). The RNA reads have been placed in the 230 
Sequence Read Archive under accession numbers SAMN11334652 through 231 
SAMN11334656. 232 
  233 
2.6) DNA preparation, genome sequencing and variant detection 234 
Genomic DNA of inbred MR-VP and each selection and control population was extracted 235 
from female mites according to Van Leeuwen et al. (Van Leeuwen et al., 2008). Briefly, 4 × 236 
200 adult mites/population were homogenized in a 2 ml Eppendorf tube containing 800 µl of 237 
SDS buffer (2% SDS, 200 mM Tris-HCl, 400 mM NaCl, 10 mM EDTA, pH = 8.33), 238 
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followed by DNA extraction using a previously described phenol-chloroform-based protocol 239 
(Van Pottelberge et al., 2009a). Prior to adding isopropanol, the four extracts were pooled and 240 
precipitated together to obtain sufficient DNA per population. Subsequently, samples were 241 
further column-purified using an EZNA Cycle Pure Kit (Omega Bio-tek, Norcross, GA, 242 
USA) according to the manufacturer’s protocol and quantified using an ND-1000 NanoDrop 243 
spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA).  244 
 Illumina genomic DNA libraries were constructed, and sequencing was performed to 245 
generate paired-end reads of 101 bp (inbred MR-VP strain) or 125 bp (all other samples). 246 
Library construction and sequencing was performed at either the Centro Nacional de Análisis 247 
Genómico (CNAG, Barcelona, Spain) for inbred MR-VP strain or the Huntsman Cancer 248 
Institute of the University of Utah (Salt Lake City, UT, USA) (all segregating populations). 249 
Genomic sequence reads for strain MR-VP and the segregating populations have been 250 
deposited in the Sequence Read Archive under accession numbers SAMN11350708-251 
SAMN11350748. Illumina reads were aligned to the reference Sanger draft T. urticae genome 252 
from the London strain (Grbić et al., 2011) using the default settings of the Burrows-Wheeler 253 
Aligner (BWA) version 0.7.15-r1140 (Li and Durbin, 2009) and processed into position-254 
sorted BAM files using SAMtools 1.3.1 (Li et al., 2009). Following recommendations 255 
described in the Genome Analysis Toolkit (GATK) best practices pipeline (Van der Auwera 256 
et al., 2013), duplicates were marked using Picard tools 2.6.0 257 
(https://broadinstitute.github.io/picard), followed by indel realignment with GATK version 258 
3.6.0-g89b7209 (McKenna et al., 2010). Joint variant calling across all 40 populations and the 259 
parental strains was carried out with GATK’s UnifiedGenotyper tool to produce a variant call 260 
format (VCF) file containing single nucleotide polymorphisms (SNPs) and indels. 261 
 262 
2.7) Quality control on predicted variants 263 
To be informative for downstream genetic analyses, variants needed to segregate (i.e., be 264 
fixed for contrasting alleles in the MR-VP and Wasatch inbred parental strains) and be of high 265 
quality. SNPs were therefore selected according to the following criteria, which were adapted 266 
from the hard-filtering recommendations in GATK post #2806 267 
(https://gatkforums.broadinstitute.org/gatk/discussion/2806/howto-apply-hard-filters-to-a-268 
call-set, accessed 9 July 2018): (1) have a minimum quality score normalized by allele depth 269 
(QD; this and subsequent acronyms and abbreviations refer to how the metrics appear in the 270 
VCF 4.2 standard) of 2, (2) mean root square mapping quality (MQ) of at least 50, (3) strand 271 
odds ratio (SOR) below 3, (4) mapping quality rank sum (MQRankSum) higher than or equal 272 
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to -8, (5) rank sum for relative positioning of alleles in reads (ReadPosRankSumTest) of at 273 
least -8, and (6) be within 25% and 150% of the sample’s genome-wide mean SNP read 274 
coverage to minimize false heterozygous variant calls caused by copy number variable 275 
regions (see also Wybouw et al., 2019); this was calculated using total depth per allele per 276 
sample (AD). 277 
 278 
2.8) Responses to selection and validation of the T. urtiace three-chromosome assembly  279 
For most downstream analyses, we transformed variant positions as assessed on the T. urticae 280 
draft Sanger genome assembly onto the recently reported T. urticae three-chromosome 281 
assembly (Wybouw et al., 2019). For simplicity, we refer to pseudochromosomes 1-3 in this 282 
assembly as chromosomes 1-3 (Chr1-3). This assembly was constructed with replicated 283 
population allele frequency data from 22 populations in an earlier study, and was partially 284 
validated with short-read de novo assemblies from multiple T. urticae strains (Wybouw et al., 285 
2019). The authors of this study noted that additional, dense population allele frequency 286 
would be important to validate the assembly. To do this, and to assess the appropriateness of 287 
the assembly for use in our study, we calculated the average window distance (AWD) metric 288 
across Chr1-3 using the allele frequency data of all of our 39 individual population samples 289 
(one of the 40 segregating populations was excluded from the analysis, see Section 2.10). 290 
Briefly, as assessed from highly replicated population allele frequency data, positive 291 
deflections of the AWD metric by position in genome-wide scans detect assembly errors; our 292 
implementation of AWD calculations followed that of Wybouw et al. (2019). 293 
 294 
2.9) Heterozygosity estimates 295 
To verify that strains MR-VP and Wasatch were inbred to fixation, we used a separate joint 296 
variant call analysis to estimate genome-wide levels of heterozygosity. Briefly, to improve 297 
variant call accuracy, and to provide an expectation for inbreeding to homozygosity, we 298 
included, in addition to MR-VP and Wasatch, previously published inbred and non-inbred 299 
sequenced strains of T. urticae (Albino-JP, Foothills, Lon-Inb, MAR-AB, PA2, SR-VP; 300 
(Bryon et al., 2017; Wybouw et al., 2019)). The predicted variants were filtered as described 301 
above, with modifications and additional filtering steps to reduce the number of false 302 
positives. Specifically, MQRankSum and ReadPosRankSumTest filters were bidirectional, 303 
meaning we kept alleles that fell between -8 and 8 for both. In addition, to prevent copy 304 
number variable regions from falsely elevating the heterozygosity estimates, only alleles 305 
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falling within 25% of the mean genome-wide SNP coverage depth for each strain were 306 
considered. The extent of heterozygosity, as assessed from counts for alleles at high-quality 307 
SNP positions in sliding windows, was visualized genome-wide. 308 
 309 
2.10) Principle component analysis 310 
A principal component analysis (PCA) was performed in R version 3.4.3 (R Developement 311 
Core Team, 2015). A correlation matrix containing the individual SNP frequencies for 312 
specific alleles was used as input for the R function prcomp, which is part of the R-package 313 
‘stats’ (version 3.3.0). We selected only those SNP alleles that were present in all treatments 314 
(fenpyroximate-selected, pyridaben-selected, tebufenpyrad-selected and control). The PCA 315 
plots were created with autoplot, a function of the R-package ‘ggplot2’ (version 2.1.0) 316 
(Wickham, 2009). An examination of the resulting PCA analysis identified an extreme outlier 317 
in the pyridaben-selected group (Fig. S1), presumably reflecting contamination by an 318 
unrelated strain; this sample, P9, was therefore excluded from all subsequent analyses, and a 319 
PCA with all samples except P9 was then generated. 320 
 321 
2.11) Bulked segregant analysis genetic mapping 322 
The ~590,400 loci from strains MR-VP and Wasatch were analyzed using BSA methods 323 
adapted from earlier studies (Bryon et al., 2017; Demaeght et al., 2014; Van Leeuwen et al., 324 
2012; Wybouw et al., 2019). The difference in MR-VP allele frequency between the 325 
acaricide-selected and the control samples was averaged for each pesticide treatment in 326 
overlapping 75kb genomic windows with 5kb offsets. Statistical significance of BSA peaks, 327 
as assessed across all replicates, was determined with the permutation approach of Wybouw 328 
et al. (2019). Briefly, in replicated BSA data, responses to selection among independent 329 
replicates are expected to co-occur at the same genomic locations. Alternatively, where minor 330 
peaks are solely due to drift, no systematic co-occurrence between replicates is expected. The 331 
permutation method implemented by Wybouw et al. (2019) assigns genomic regions 332 
responding to selection across samples (concerted responses at specific genomic locations) 333 
from multigenerational, replicated unselected and selected populations by establishing a 334 
significance threshold for QTL detection at a specified genome-wide false discovery rate 335 
(FDR). The permutation method requires pairing of selected and unselected samples. In this 336 
study, we adapted the sample matching approach that Wybouw et al. (2019) applied to the 337 
same experimental design to detect a QTL for host plant adaptation using five selected and 338 
unselected populations. An exception was that, as the current study used many more 339 
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replicates – 9 for pyridaben and 10 for fenpyroximate and tebufenpyrad (hence 9! and 10! 340 
potential pairings) – subsets of 120 potential pairings were chosen to make it computationally 341 
feasible. For each of the 120 sets, 5% FDR thresholds for QTL detection were calculated from 342 
the distribution of maximal allele frequency values for 104 permutations as described by 343 
Wybouw et al. (2019). Across the entire set of 120 permutations, the most conservative 5% 344 
FDR cutoff was used for QTL assignment.  345 
 346 
2.12) Predicted effects of genetic variants in coding sequences 347 
To assess coding sequence changes in genomic (QTL) regions for response to pesticide 348 
selection, coding effects of SNPs and small indels identified by the GATK analysis were 349 
predicted using SnpEff 4.2 (Cingolani et al., 2012) with a T. urticae coding sequence database 350 
derived from the June 23, 2016 annotation available from the Online Resource for 351 
Community Annotation of Eukaryotes (ORCAE) (Sterck et al., 2012). The QTL were also 352 
visually inspected in Integrative Genomics Viewer (IGV) version 2.3.90 (Robinson et al., 353 
2011). 354 
 355 
2.13) Alignment of CPR proteins 356 
All protein sequences used in the alignment were accessed either using the UniProt database 357 
(Bateman et al., 2015): (T. urticae (tetur18g03390), H. sapiens (NP_000932.3), R. norvegicus 358 
(NP_113764.1), M. domestica (NP_001273818.1) and D. melanogaster (NP_477158.1) or 359 
NCBI: C. sculpturatus (XP_023225549.1). The sequences were aligned using Clustal W 360 
version 2.1 (Larkin et al., 2007).  361 
 362 
2.14) Gene duplication of the DNA-binding domain (DBD)-lacking nuclear hormone receptor 363 
(NHR-96)-like gene within a QTL connected with tebufenpyrad selection.  364 
De novo assemblies of inbred strains MR-VP and Wasatch were constructed from paired-end 365 
Illumina data using CLC Genomics Workbench 9.0.1 366 
(https://www.qiagenbioinformatics.com). Reads were imported and trimmed using the “Trim 367 
Sequences” tool prior to assembly with the “De Novo Assembly” tool; default settings were 368 
used for both. Contigs from the de novo assemblies were aligned to the London reference 369 
genome using the default settings of BLASR 1.3.1 (Chaisson and Tesler, 2012) with soft-370 
clipping enabled. Contig sequences aligning to the DBD-lacking NHR 96-like gene in the 371 
QTL region for response to tebufenpyrad (tetur06g04270) were extracted (File S1) and their 372 
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open reading frames (ORFs) determined using ExPASy (Gasteiger et al., 2003). RNA-seq 373 
alignments were performed using Spliced Transcripts Alignment to a Reference (STAR) 374 
version 2.5.3a (Dobin et al., 2013), with the two-pass mode and a maximum intron size of 20 375 
kb; the RNA-seq reads were aligned to a modified version of the London reference sequence 376 
that was adjusted to include an MR-VP de novo assembled contig in the genomic region 377 
spanning tetur06g04270. Gene duplications in both Wasatch and MR-VP de novo contigs 378 
were annotated (File S2) based on the ORF information and the MR-VP RNA-seq alignment 379 
visualization in IGV version 2.3.90 (Robinson et al., 2011). 380 
 381 
2.15) Analysis of DBD-lacking NHR96-like genes in T. urticae: manual reannotation, 382 
phylogeny, and genomic distribution. 383 
The T. urticae genome was mined for other DBD-lacking NHR96-like genes by using the 384 
eight conserved NHR96-like ligand binding domains (LBDs) as queries in tBLASTn and 385 
BLASTp searches (e-value threshold of e-3, BLAST+ version 2.2.31) against the T. urticae 386 
genome (Grbić et al., 2011) and proteome (version of 11 August, 2016), respectively. T. 387 
urticae gene models were modified when necessary or new gene models were created using 388 
GenomeView version N39 (Abeel et al., 2012). The DBD-lacking NHR96-like sequences can 389 
be found in File S3. To test for evidence of other tandem duplications of DBD-lacking T. 390 
urticae NHR-like genes, Chr1-3 and the smaller unplaced scaffolds were scanned for regions 391 
where at least two DBD-lacking NHR genes occurred in the same orientation with 50kb or 392 
less between each pair of genes within the cluster. 393 
 Subsequently, nuclear receptor sequences were obtained for Drosophila 394 
melanogaster, Daphnia pulex and T. urticae (Grbić et al., 2011; King-Jones and Thummel, 395 
2005; Thomson et al., 2009) accession numbers can be found in Table S1. Using Pfam 31.0 396 
(Finn et al., 2016), each receptor sequence was analyzed for the presence of a conserved LBD 397 
(PF00104). Detected LBDs were aligned to those of the mined candidate T. urticae DBD-398 
lacking NHR96-like peptides using MAFFT version 7 with the E-INS-i iterative refinement 399 
method strategy (Katoh et al., 2002). A phylogenetic analysis was performed on the CIPRES 400 
web portal (Miller et al., 2010) using RAxML version 8 HPC2-XSEDE (Stamatakis, 2014) 401 
with the automatic protein model assignment algorithm using maximum likelihood criterion 402 
and 1000 bootstrap replicates; the LG + G protein model was selected as the optimal model 403 
for analysis. The resulting tree was midpoint rooted, visualized using MEGA6 (Tamura et al., 404 
2013) and edited in CorelDRAW Home & Student X7 (Corel, Austin, TX, USA). 405 
 406 
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2.16) NHR-like genes lacking DBD in other arthropods  407 
To determine if DBD-lacking NHR genes (including DBD-lacking NHR96-like genes) were 408 
common in other arthropods, we used two approaches: one relying on comprehensive 409 
searches of the NCBI nr database (downloaded 13 June, 2018) for DBD-lacking NHR-like 410 
genes using keywords, and the other based on BLASTp (version 2.7.1) searches with DBD-411 
lacking NHR96-like T. urticae gene queries against the same database; the latter approach 412 
was undertaken to find NHR-like genes that had not been annotated. Using the first approach, 413 
we extracted all protein sequences that had “nuclear receptor”, “hormone receptor”, or 414 
“ecdysone” in their description; the last keyword was used as many insect NHRs are involved 415 
in molting and metamorphosis (Fahrbach et al., 2012). For the second approach, we used as 416 
queries each of the 47 DBD-lacking NHR96-like genes present in the London genome 417 
sequence of T. urticae, as well as the two copies of the tetur06g04270 gene from strain 418 
Wasatch. We allowed 1000 results for each search and then extracted all the resulting proteins 419 
that aligned with an e-value of 1 or below. 420 
 From the protein sequences obtained using both approaches, we only kept those 421 
belonging to Arthropoda as assessed with the Python package ete3 (version 3.1.1) (Huerta-422 
Cepas et al., 2016). InterProScan version 5.29-68.0 was then used to predict domains and 423 
conserved regions. From the resulting sequences, we extracted those that were classified by 424 
InterProScan as “nuclear hormone receptor-like domain superfamily” (IPR035500), and that 425 
lacked the “Zinc-finger, nuclear hormone receptor type” motif (IPR001628) (Zdobnov and 426 
Apweiler, 2001). In the event that several proteins had the same amino acid sequence, only 427 
one was retained for analysis. 428 
3) Results 429 
3.1) Characterization of METI-I resistant inbred strains  430 
To facilitate genetic and genomic analyses, strain MR-VP was mother-son inbred for six 431 
generations, a level of inbreeding similar to that of strain Wasatch, which was performed in 432 
an earlier study (Bryon et al., 2017). To confirm that the strains were isogenic, we sequenced 433 
the MR-VP strain using the Illumina method, and aligned the resulting reads, as well as those 434 
from Wasatch and several other strains sequenced previously (Bryon et al., 2017), to the 435 
London reference genome. For strains like MAR-AB and Albino-JP, which were either not 436 
inbred, or only inbred for one generation (Bryon et al., 2017), heterozygosity was observed at 437 
82.14% and 10.29% of SNP sites, respectively. In contrast, for MR-VP and Wasatch, only 438 
1.77% and 1.14% of variable positions were not fixed (Fig. S2), respectively, perhaps 439 
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reflecting sequencing errors or errant predictions in copy number variable regions. Toxicity 440 
bioassays revealed that the inbred MR-VP and Wasatch strains varied greatly in their 441 
susceptibility to METI-Is, with MR-VP withstanding 190-, 532- and 73-fold higher 442 
concentrations of fenpyroximate, pyridaben and tebufenpyrad, respectively (Table 1). In fact, 443 
MR-VP’s LC50 for fenpyroximate could not be calculated as it exceeded 5000 mg a.i. L-1. 444 
 445 
3.2) Evolution of METI-I acaricide resistance in experimental mite populations  446 
To establish a segregating population for genetic mapping of resistance, we crossed MR-VP 447 
to Wasatch, and then crossed the F1 hybrid population back to Wasatch. This backcross was 448 
performed to maximize the recombination of haplotypes contributed by the resistant MR-VP 449 
strain. After the resulting population was allowed to expand in bulk for several generations, 450 
ten subpopulations were established for each of the three acaricide treatments, in addition to 451 
ten control subpopulations (see Materials and Methods). The 40 resulting populations were 452 
reared in separation in a greenhouse on whole bean plants for over nine months (~25 453 
generations). During that time, each population in the three treatment groups was adapted to 454 
gradually increasing concentrations of acaricide, ending with the final concentrations of 3500 455 
mg a.i. L-1 fenpyroximate, 1250 mg a.i. L-1 pyridaben, and 750 mg a.i. L-1 tebufenpyrad. 456 
Afterwards, the selected and the control populations were tested at 2500 mg a.i. L-1 of each 457 
acaricide, which proved to be a discriminating concentration that showed a clear distinction 458 
between resistant and sensitive populations (Fig. 1). All three acaricide-selected population 459 
groups showed significantly higher survival rates compared to the control populations (p < 460 
0.0001, generalized mixed model).  461 
 462 
3.3) Genomic responses to selection 463 
Following the experimental selections, we extracted DNA from each of the 40 populations 464 
and performed genome sequencing to produce a per-sample Illumina read coverage ranging 465 
from 58 to 78 (based on the Variant Call Format [VCF] file; see Materials and Methods). As 466 
revealed from alignments of the resulting reads, and those of the MR-VP and Wasatch 467 
parents, to the T. urticae reference genome (London strain, Grbić et al., 2011), ~590,400 468 
high-quality SNP variants were identified as segregating in the experimental populations. To 469 
test for responses to selection, we performed PCAs using the genome-wide variant predictions 470 
(Fig. 2). As a preliminary PCA revealed that one pyridaben population was contaminated by 471 
an unknown strain (Fig. S1), the analysis was repeated excluding that sample. For the control, 472 
fenpyroximate-selected and tebufenpyrad-selected populations, tight clustering was apparent, 473 
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with no overlap among populations by treatment. Along PC1, which explained 39.4% of the 474 
variation, pyridaben- and tebufenpyrad-selected populations clustered separately from control 475 
and fenpyroximate-selected populations. However, along PC2 (7.2% of the variation), 476 
pyridaben-selected populations were markedly more dispersed as compared to the other 477 
treatment groups, consistent with a more heterogeneous response to selection by pyridaben as 478 
opposed to the other two acaricides.  479 
 480 
3.4) Regional genomic responses to selection and validation of the three-chromosome assembly  481 
As the principle component analysis (PCA) was consistent with genome-wide responses to 482 
selection by each acaricide, we assessed the frequency of the MR-VP alleles in sliding 483 
windows along Chr1-3 in the consolidated genome assembly recently reported by Wybouw et 484 
al. (2019). For the control, fenpyroximate and tebufenpyrad treatments, allele frequencies for 485 
populations within treatment groups were highly correlated, as they were between treatment 486 
groups over much of the genome length. For the pyridaben populations, greater variation was 487 
observed, consistent with the findings of the PCA. A potential explanation for this result is 488 
that the pyridaben populations went through a more severe bottleneck during acaricide 489 
selection as compared to the selections with the other two compounds (during a bottleneck 490 
event, the effect of genetic drift is elevated). Nevertheless, systematic differences were 491 
observed in allele frequencies between the control populations and those in each acaricide 492 
treatment group (e.g., at ~30Mb on Chr1), identifying putative regions for adaptation. Using 493 
the population allele frequency data from the control and the fenpyroximate-selected, 494 
pyridaben-selected and tebufenpyrad-selected populations, we also calculated the average 495 
window distance (AWD) metric along the lengths of Chr1-3 (Fig. S3); positive deflections in 496 
this metric are indicative of assembly errors, see Wybouw et al. (2019) and Materials and 497 
Methods. As no such errors were apparent (confirming the integrity of the three-chromosome 498 
assembly), we used this chromosome-level assembly for all further analyses. 499 
 500 
3.5) Population bulked segregant analysis mapping of QTL  501 
To detect genomic intervals that responded to acaricide selections, we tested for significant 502 
deviations in allele frequencies between fenpyroximate, pyridaben and tebufenpyrad treated 503 
populations as compared to the control populations. Using a permutation-based framework for 504 
establishing QTL significance that takes into account all replicate data (see Materials and 505 
Methods) adapted from Wybouw et al. (2019), we identified one or more QTL for resistance 506 
for each of the three acaricides at a FDR of 5% (Fig. 3). Within an acaricide-control 507 
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comparison, QTL were prefixed with the acaricide, and numbered in order from strongest to 508 
weakest as assessed by the magnitude of the allele frequency deviations. In all cases, 509 
significant QTL reflected selection for alleles contributed by the resistant MR-VP parent. For 510 
each QTL region, we analyzed genes and genetic variants in the top 75kb window as assessed 511 
from the BSA genomic scans. 512 
 All three acaricide-selected groups shared a QTL at a coincident location at ~30Mb on 513 
Chr1 (fenpyroximate-, pyridaben- and tebufenpyrad-QTL 1; Fig. 3A-C, respectively). 514 
Strikingly, in all the METI-I-selected populations, the haplotype contributed by the resistant 515 
MR-VP strain went to complete (or nearly complete) fixation (Fig. S3A-C). The top windows 516 
for each of these three QTL all harbored NADH: ubiquinone oxidoreductase (also known as 517 
PSST, tetur07g05240), and the putative H92R target-site resistance allele for fenpyroximate, 518 
pyridaben, and tebufenpyrad (Bajda et al., 2017), among a total of 21 genes in the collective 519 
region of 80kb spanning the three peak windows of response (Fig. 4; Table S2).  520 
In addition, for the pyridaben and tebufenpyrad selections, a QTL for resistance was 521 
also observed at a coincident location on Chr2 (at ~5.7Mb, pyridaben- and tebufenpyrad-QTL 522 
2; Fig. 3B,C, respectively). The top 75kb peak genomic windows overlapped exactly for these 523 
two QTL, and the region harbored 27 annotated genes (Table S3). Within this region, 524 
cytochrome P450 reductase (CPR, tetur18g03390), which encodes an enzyme required for 525 
P450 function (Demaeght et al., 2013; Riga et al., 2015), was located within 20kb of the 526 
maximal allele frequency deviations (Fig. 4B). An analysis of the MR-VP haplotype revealed 527 
that it was identical to that of the spirodiclofen-resistant strain SR-VP studied by Wybouw et 528 
al. (2019); in this study, the authors identified a nonsynonymous variant, D384Y, as unique to 529 
SR-VP and only one other strain published to date. While this variant was also present in MR-530 
VP, it was absent in the METI-I sensitive parent, Wasatch. 531 
  A QTL at ~12.5Mb on Chr1 was specific for the tebufenpyrad group (tebufenpyrad -532 
QTL 3, Fig. 3C; while pyridaben-selected populations also showed elevated MR-VP allele 533 
frequencies in this region, they did not pass the significance threshold). The top window for 534 
response to tebufenpyrad selection was located near a DNA-binding domain (DBD)-lacking 535 
nuclear hormone receptor 96 (NHR96)-like gene (tetur06g04270), among a total of 15 genes 536 
(Table S4).  537 
In addition, we noted that the pyridaben- and tebufenpyrad-selected populations had 538 
elevated frequencies of MR-VP alleles, relative to the control populations, over a broad 539 
region from about 20-25Mb on Chr1. Although portions of this large interval passed the 540 
threshold for QTL detection, the region is located along the proximal slope of the large 541 
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response region for pyridaben- and tebufenpyrad-QTL 1. Whether this region reflects one or 542 
more independent QTL, or rather the physical proximity to QTL 1 (hitchhiking due to 543 
linkage), will require additional investigation.  544 
 545 
3.6) Analysis of D384Y mutation in CPR 546 
The D384Y change in the CPR gene of MR-VP was first reported in a genomic region that 547 
showed significant response to spirodiclofen selection in T. urticae strain SR-VP (Wybouw et 548 
al., 2019). The CPR gene is highly conserved in all organisms and therefore alignments and 549 
modeling on known CPR structures are straightforward. Fig. 5 shows an alignment of the T. 550 
urticae CPR sequence with other animal CPRs in the region surrounding D384. When 551 
modeling CPR with Phyre2 (Kelley et al., 2015), an excellent match with rat CPR (pdb: 552 
c1j9zB) was obtained (score of 1184.13, e-value = 0, probability 100% with 58% identities). 553 
Spider mite D384, which corresponds to rat or human Q391, was located on the surface of the 554 
protein, specifically at the end of alpha helix I (nomenclature of Wang and Roberts, 1997) in 555 
the connecting domain between the conserved FAD/NADPH and FMN domains. This region 556 
is not implicated in flavin cofactor or NADP(H) binding, and is distant from the short “hinge” 557 
connecting the two flavin domains of CPR. Hence, the mutation was not predicted to interfere 558 
in any major and obvious way with electron transfer from NADPH to FAD and FMN, or 559 
electron transfer between the reductase and P450, but it may have more subtle effects (see 560 
Discussion section 4). 561 
 562 
3.7) Nuclear hormone receptor analysis 563 
We identified a DBD-lacking NHR96-like gene (tetur06g04270) as one of the candidate 564 
genes potentially linked with tebufenpyrad resistance. Aligning de novo assembled contigs to 565 
the three-chromosome assembly suggested that T. urticae strains MR-VP and Wasatch both 566 
harbored two copies of the DBD-lacking NHR96-like gene in tandem in a head-to-tail 567 
orientation. Next, to verify gene models and to determine if the genes were expressed, we 568 
aligned MR-VP RNA-seq reads to a copy of the three-chromosome assembly in which a de 569 
novo assembled MR-VP contig spanned the tetur06g04270 region in place of the original 570 
sequence. As the RNA reads uniquely mapped to each gene, the alignments confirmed the 571 
presence of the duplication and showed that both genes were expressed in MR-VP (Fig. S4). 572 
The NR1J group represented in insects by the single NHR96 receptor was shown to be 573 
expanded in T. urticae, where eight NHR96-like genes were found (Grbić et al., 2011). 574 
18 
 
However, all of them contained the DBD. In this study, we annotated DBD-lacking NHR96-575 
like genes in the T. urticae genome and identified 47 genes that had a ligand-binding domain 576 
(LBD) most similar to the eight canonical NHR96-like genes previously reported (Cheng et 577 
al., 2008; Grbić et al., 2011; Robinson-Rechavi et al., 2003; Thomson et al., 2009), but that 578 
lack the DBD (Fig. 6, panel A). Most DBD-lacking NHR96-like genes in T. urticae (37/47) 579 
occurred in clusters (i.e., within 50kb of another DBD-lacking NHR-gene in a head-to-tail 580 
orientation) of up to seven genes, suggesting sequential duplication events (Fig. 6B).  581 
 To determine if DBD-lacking NHR-like (and specifically, NHR96-like) peptides were 582 
common in other arthropods, we comprehensively searched the NCBI database for NHR-like 583 
DBD-lacking proteins. By far the most common types of previously annotated DBD-lacking 584 
NHR-like receptors were E75s (88 in total), followed by FTZ-F1s (44), E78s (41), and 585 
photoreceptors (20). DBD-lacking NHR96-like genes, on other hand, appeared to be 586 
relatively rare. Our nr database search only identified a single annotated DBD-lacking 587 
NHR96 peptide in each of the following species: Agrilus planipennis, Centruroides 588 
sculpturatus, Drosophila miranda, Plutella xylostella, and Rhagoletis zephyria. 589 
 590 
4) Discussion 591 
Previous investigations into METI-I resistance in MR-VP revealed that fenpyroximate and 592 
pyridaben resistance were inherited as a monogenic and dominant trait, whereas resistance to 593 
tebufenpyrad was polygenic and incompletely dominant (Van Pottelberge et al., 2009b). 594 
Subsequently, sequencing of several subunits presumably making up the target/binding-site 595 
identified a nonsynonymous H92R change in the PSST subunit of NADH:ubiquinone 596 
oxidoreductase, which was significantly associated with resistance (Bajda et al., 2017). 597 
Nevertheless, the introgression of this mutation into a susceptible genetic background 598 
revealed that the H92R variant alone failed to explain the strength of the resistance phenotype 599 
to any of the three acaricides. This suggested roles for other loci and alleles in resistance. 600 
In this study, we subjected a segregating population (parental strains MR-VP and 601 
Wasatch, which are resistant and sensitive, respectively) to multiple rounds of selection by 602 
three METI-Is, and used BSA genetic mapping to identify loci responding to selection for 603 
each acaricide. While the H92R change played a significant role in resistance to each 604 
acaricide, one additional genomic region was significantly associated with resistance to both 605 
pyridaben and tebufenpyrad, and a further QTL was identified for tebufenpyrad resistance 606 
alone. The peak regions of response for both additional QTL harbored candidate genes 607 
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encoding an enzyme or putative receptors associated directly or indirectly with xenobiotic 608 
detoxification (CPR, and two tandem NHR96-like genes lacking DBDs). The candidate 609 
genes, and in some cases putative variants for QTL, are discussed below, although for CPR 610 
and the NHR96-like genes our conclusions are speculative. 611 
The target-site H92R variant in the PSST subunit was coincident with the most 612 
prominent peak in all three BSA scans (QTL 1). The unselected populations were relatively 613 
resistant compared to the susceptible parent (Fig. 2), presumably reflecting the high frequency 614 
of the H92R variant in the unselected populations – about 0.5 after ~25 generations in the 615 
experimental evolution experiment (Fig. S3) – likely reflecting the partially dominant nature 616 
of the change (Van Pottelberge et al., 2009b). This pattern reveals that contrary to the fitness 617 
cost associated with some resistance mutations in T. urticae (Riga et al., 2017) and the 618 
lethality of the corresponding substitution in Drosophila melanogaster (Bajda et al., 2017), 619 
there is no major fitness cost associated with the T. urticae H92R substitution. The earlier 620 
work, as well as our current study, suggest that mutations occurring in this conserved part of 621 
the PSST subunit can have species-specific effects on fitness. Further, mutations in the 622 
adjacent PSST subunit residue M91 in the aerobic yeast Yarrowia lipolytica decreased 623 
enzymatic activity of complex I (Fendel, 2008), but had no effect on Vmax when binding 624 
ubiquinone-1 and even increased Vmax involving ubiquinone-2, which has a longer isoprenoid 625 
side chain (Angerer et al., 2012; Fendel et al., 2008). 626 
In addition to the target-site change, mites selected to pyridaben and tebufenpyrad 627 
showed significant responses in other genomic regions. This was consistent with the 628 
previously reported incompletely dominant inheritance of tebufenpyrad resistance, but 629 
contradicted an earlier result, which classified resistance to pyridaben as monogenic (Van 630 
Pottelberge et al., 2009b). The likely explanation is that Van Pottelberge and colleagues used 631 
a fairly recently collected outbred MR-VP strain, while we used an inbred derivative of the 632 
same strain after it had been maintained in the lab for ~11 years under constant selection 633 
(minor effect alleles may have been selected in the laboratory as acaricide concentrations 634 
become high enough to overcome target-site resistance).  635 
Introgression of the H92R resistant allele into a sensitive background only resulted in 636 
a fraction (average of 578 mg L-1 (Bajda et al., 2017)) of the MR-VP fenpyroximate resistance 637 
phenotype observed in both this study (>5000 mg L-1) and in Van Pottelberge et al. (10,581 638 
mg L-1). Nevertheless, fenpyroximate resistance appeared to be monogenic in both Van 639 
Pottelberge et al. as well as in our study. While most of the resistance phenotype was likely 640 
due to multiple alleles of minor effect that could not be detected by our methods, it remains 641 
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unknown why neither of the two genomic regions associated with selection to the other 642 
acaricides showed a significant association with fenpyroximate resistance. Evidence from 643 
functional cytochrome P450 expression in E. coli as well as from the application of a selective 644 
P450-inhibiting synergist piperonyl butoxide (PBO) suggests that fenpyroximate’s 645 
metabolism is different from that of pyridaben and tebufenpyrad (see below). The divergent 646 
genomic response to selection could thus be related to metabolic resistance, and specifically, 647 
to differences in P450-mediated detoxification. 648 
The second most prominent BSA peak (QTL 2) in the tebufenpyrad- and pyridaben-649 
selected T. urticae centered on a D384Y mutation in the electron transfer flavoprotein CPR 650 
(Wybouw et al., 2019). CPR is an essential enzyme in all eukaryotes that serves as an electron 651 
donor protein for all microsomal P450s and several other enzymes found in the endoplasmic 652 
reticulum of most cells (Murataliev et al., 2004). CPR was not differentially expressed in MR-653 
VP compared to the METI-I susceptible strain London (Dermauw et al., 2013). Therefore, the 654 
D384Y mutation likely does not affect the expression of CPR. Instead, it is possible that the 655 
mutation is advantageous by improving P450 detoxification pathways. 656 
The idea that a mutation in CPR can be implicated in resistance development by 657 
interacting with relevant P450s in trans is attractive, because detoxification of METI-Is is 658 
thought to be mostly P450-based (Cho et al., 1995; Devine et al., 2001; Herron and Rophail, 659 
1998; Ozawa, 1994; Van Pottelberge et al., 2009b). This, however, raises the question of why 660 
selection to fenpyroximate did not favor the mutation. Possible explanations include the 661 
relative specificity of P450s that metabolize acaricides as well as the relative specificity in the 662 
interactions of CPR with P450s. P450 specificity towards acaricides is supported by evidence 663 
that certain P450s target fenpyroximate, but do not act on the other two acaricides; 664 
CYP392A11, a P450 that is overexpressed in MR-VP compared to the METI-I sensitive strain 665 
London (Dermauw et al., 2013), hydrolyzes fenpyroximate but not pyridaben or tebufenpyrad 666 
when expressed in E. coli (Riga et al., 2015). Evidence that other P450s may also fall into this 667 
pattern comes from treatment with the synergist PBO, which does not suppress every P450 668 
equally (Feyereisen, 2015). Work on strain MR-VP prior to inbreeding showed that PBO 669 
significantly decreased resistance to pyridaben and tebufenpyrad, but had little effect on 670 
fenpyroximate resistance (Van Pottelberge et al., 2009b), likely because PBO did not 671 
sufficiently target P450s that metabolize fenpyroximate. Specificity in the interactions of CPR 672 
with P450 is supported by evidence that human variants in CPR differentially affect various 673 
P450 activities (Burkhard et al., 2017). The only known human CPR variant with increased 674 
activity is Q153R, and the effect of this mutation is positive on CYP19A1 and CYP3A4 675 
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activities but negative on CYP17A1 and CYP51A1 (Udhane et al., 2017). Furthermore, P450 676 
activity is directly related to the concentration of the CPR-P450 complex (Murataliev et al., 677 
2008), whose dissociation constant depends on the structure of each P450. Consequently, the 678 
D384Y mutation may have a greater effect on P450s that specifically metabolize pyridaben 679 
and tebufenpyrad. 680 
It remains unclear from X-ray crystallography alone how the D384Y mutation can 681 
affect P450 activity. The position of D384 on the surface of the protein in the connecting 682 
domain of CPR would rule out an effect on FAD, FMN or NADP(H) binding. D384 is also 683 
located far from the short hinge region that allows the approximately 90-degree rotation of the 684 
FMN domain away from the FAD-linker domain seen between the open and closed 685 
conformations of CPR (Aigrain et al., 2009; Hamdane et al., 2009). It does not point towards 686 
the space expected to be occupied by P450s in the open conformation of CPR, and 687 
superimposition of the open and closed structures indicates little if any movement of the 688 
residue at position D384. These considerations rule out a major effect on FAD to FMN to 689 
P450 electron transfer. The connecting domain and helix I of CPR are also predicted to 690 
remain distant from the ER membrane surface in either open or closed conformations 691 
(Laursen et al., 2011). The D384Y mutation has not been documented in human variants of 692 
CPR (where the homologous mutation would be E394Y), and the closest human variants 693 
S397L or E398A are not associated with any known pathology (Burkhard et al., 2017). 694 
The D384Y mutation additionally introduces a YY dipeptide in the structure. The 695 
possible pi-stacking (McGaughey et al., 1998) of the two adjacent aromatic rings might affect 696 
protein stability, or cause subtle long-range changes in conformational dynamics which are 697 
known to take place during catalysis (Murataliev and Feyereisen, 2000). Moreover, the 698 
solution structure of the CPR may differ from the crystal structure in subtle ways (Huang et 699 
al., 2013). A model of the extended (open) conformation of human CPR based on solution 700 
NMR and small angle X-ray scattering experiments indicates that four residues of helix I of 701 
the connecting domain, including the homologous Q391, make polar interactions with the 702 
FMN domain (Huang et al., 2013). If this model faithfully represents the changes in the 703 
structure of CPR during catalysis, then the most likely explanation for an effect of the D384Y 704 
mutation would be a subtle change in the stability of the interaction between the connecting 705 
domain and the FMN domain in the open conformation, which is the conformation in which 706 
electrons are transferred from FMN to P450s.  707 
Given the conservation of sequence, the homologous mutation to D384Y would be 708 
E395Y in D. melanogaster. Therefore, the fly may be suitable for studying the effect of the 709 
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mutation in vivo by a reverse genetic approach using CRISPR-Cas9 technology combined 710 
with homologous recombination-directed gene modification. An intriguing possibility to 711 
explore is that the D384Y mutation has a fitness cost to mites that are not exposed to 712 
pesticides. The BSA peak centering on the mutation results not from elevated MR-VP 713 
frequency in the acaricide-treated groups, but rather in relatively low MR-VP allele 714 
frequencies in mites from control populations (i.e., in the absence of selection, the variant 715 
rapidly decreased in allele frequency, Fig. S3B-C); the same pattern was also observed when 716 
the genomic region surrounding the allele was associated with spirodiclofen resistance in SR-717 
VP, a different strain of T. urticae (Wybouw et al., 2019), in which it was also shown that 718 
P450s are involved in spirodiclofen resistance (Demaeght et al., 2013; Van Pottelberge et al., 719 
2009a). 720 
Another protein that may be involved in detoxification by way of P450 regulation is a 721 
DBD-lacking NHR96-like gene, tetur06g04270, which appears in two tandem copies in both 722 
sensitive and resistant parental strains; the genes fall roughly at the center of a minor BSA 723 
peak (QTL 3) in the tebufenpyrad-selected group (mites in the pyridaben-selected group also 724 
increased MR-VP derived allele frequency in that region, albeit not significantly). Most 725 
NHRs are transcription factors; a ligand-binding domain (LBD) interacts with hydrophobic 726 
signaling molecules, which then cause the NHR to affect transcription of select genes via its 727 
DNA-binding domain (DBD). The two NHR96-like genes are not canonical NHRs as they 728 
completely lack the DBD. Further genomic analyses revealed that in addition to the 729 
tetur06g04270 genes, the T. urticae genome contains 45 other NHR96-like genes that 730 
contained the LBD but were missing the DBD, and that this gene expansion appears to be 731 
unique to T. urticae (although genome information is not yet available for other spider mite 732 
species).  733 
NHRs are diverse and have many functions; they are classified into groups NR0 734 
through NR6, and into subgroups according to their highly conserved domain structure, with 735 
non-canonical NHRs that lack either the LBD or the DBD classified as NR0 regardless of 736 
origin (Nuclear Receptors Nomenclature Committee, 1999). Our comprehensive search of the 737 
NCBI database showed that E75, E78, and FTZ-F1 DBD-lacking NHR-like genes appear to 738 
be common in arthropods, but while canonical E75s, E78s and FTZ-F1s are known for their 739 
role in metamorphosis, vitellogenesis and embryogenesis (Fahrbach et al., 2012), little is 740 
known about the function of DBD-lacking NHR-like genes or how they interact with their 741 
targets. In D. melanogaster, DBD-lacking E75B acts by heterodimerizing with DHR3 742 
(Reinking et al., 2005), while a DBD-lacking DHR3 plays a role in regulating cell growth by 743 
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interacting with Drosophila ribosomal protein S6 kinase in a yet unknown fashion (Montagne 744 
et al., 2010). Since most of the work on arthropod NHRs has been done on D. melanogaster, 745 
and NHR96-like DBD-lacking genes are only known to be expanded in T. urticae, no 746 
information is currently available about their potential mode of action. Given T. urticae's 747 
polyphagous lifestyle and pest status, a connection between NHR96-like DBD-lacking genes 748 
and xenobiotic metabolism is a possibility warranting further exploration, especially 749 
considering that D. melanogaster's canonical NHR96 – which has the highest BLASTp match 750 
for either copy of tetur06g04270 – has been implicated in detoxification. Xenobiotic-751 
independent overexpression of NHR96 in D. melanogaster L3 larvae induced expression of 752 
detoxification genes (King-Jones et al., 2006), and NHR96 overexpression in the Malpighian 753 
tubules increased DDT resistance (Afschar et al., 2016). Additionally, adult NHR96 null 754 
mutants of D. melanogaster were more sensitive to chronic DDT exposure (King-Jones et al., 755 
2006), the sedative effects of phenobarbital (PB) (King-Jones et al., 2006), permethrin (a 756 
pyrethroid) (Beaver et al., 2010) and malathion (Afschar et al., 2016). Many of the genes 757 
affected by either the NHR96 loss- or gain-of-function mutations encode members of the 758 
classic detoxification enzyme families: P450s, glutathione S-transferases (GSTs), 759 
carboxylesterases, and UDP-glucuronosyl transferases (UGTs) (King-Jones et al., 2006). 760 
These gene families play key roles in detoxification across the animal kingdom, and some – 761 
like the P450s – have been expanded in T. urticae (Grbić et al., 2011). 762 
5) Conclusion 763 
In this study, we compared and contrasted selection responses to three METI-I acaricides: 764 
fenpyroximate, pyridaben, and tebufenpyrad. We found that crossing a resistant strain of T. 765 
urticae to a susceptible one and separately selecting the offspring with the three acaricides did 766 
not yield the same genetic response. While a previously identified H92R target-site mutation 767 
was significantly associated with resistance to all three METI-I acaricides, we found that 768 
additional loci were associated with resistance to pyridaben and tebufenpyrad, including a 769 
genomic region previously associated with spirodiclofen resistance. This region included a 770 
variant in CPR, which may be responsible for improving the efficiency of relevant P450s, but 771 
at a likely fitness cost in the absence of acaricide treatment. A region connected with 772 
resistance to tebufenpyrad included two tandem copies of NHR96-like proteins that lacked a 773 
DNA-binding domain, and further manual annotation revealed a total of 47 such genes in T. 774 
urticae. An NCBI database search suggested that an expansion of these genes appears to be 775 
unique to T. urticae, and their function is currently unknown. Although the role of the CPR 776 
24 
 
mutation and the DBD-lacking NHR96-like genes in xenobiotic resistance in T. urticae 777 
remain speculative, the link between the associated genetic regions and resistance to some, 778 
but not all, METI-Is, suggests that adaptation to treatment with those acaricides involves 779 
different pathways in the spider mite. 780 
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Figures 1133 
Fig. 1. Response to acaricide treatment for MR-VP × Wasatch recombinant long-term 1134 
acaricide-selected and control populations. Survival was scored in the adult stage after 1135 
spraying with 2500 mg a.i. L-1 of (A) fenpyroximate, (B) pyridaben and (C) tebufenpyrad. All 1136 
three sets of acaricide-selected populations showed significantly higher survival rates 1137 
compared to the control populations (p < 0.0001, generalized mixed model). Error bars 1138 
represent 2 × SE. The molecular structures of the three acaricides are displayed to the right of 1139 
the bar plots, with nitrogen heterocycles shaded in gray. 1140 
 1141 
Fig. 2. Principal component analysis (PCA) with control and selected populations based on 1142 
genome-wide allele frequencies at polymorphic sites. Individual populations are colored 1143 
according to the treatment group (legend, upper right). The control, fenpyroximate-selected 1144 
and tebufenpyrad-selected populations clustered tightly by treatment group, and separately 1145 
from each other. The pyridaben-selected populations clustered less tightly, but nevertheless 1146 
remained separate from control populations along PC1. 1147 
 1148 
Fig. 3. Genomic responses to acaricide selections. Bulked segregant analysis (BSA) genetic 1149 
mapping of QTL for resistance to (A) fenpyroximate (green), (B) pyridaben (blue), and (C) 1150 
tebufenpyrad (gray). Dashed lines delineate statistical significance for QTL detection (FDR of 1151 
5%). A QTL at a coincident location at ~30Mb on Chr1 (QTL 1) was observed for selection 1152 
by each acaricide, and corresponds to the target-site H92R mutation in NADH: ubiquinone 1153 
oxidoreductase (PSST). Coincident BSA peaks centered on cytochrome P450-reductase 1154 
(CPR) on Chr2 (QTL 2) and were observed in response to selection by both pyridaben and 1155 
tebufenpyrad. A less dramatic but nonetheless significant BSA peak at ~12.5Mb on Chr1 1156 
(QTL 3) was only observed in response to selection by tebufenpyrad, and is located nearby 1157 
two tandemly duplicated nuclear hormone receptor 96 (NHR96)-like genes that lack the 1158 
DNA-binding domains (DBDs). 1159 
 1160 
Fig. 4. Genes in 75kb genomic windows of peak response at QTLs 1-3. Triangles positioned 1161 
along the top and bottom boundaries of each plot represent genomic window midpoints of 1162 
each acaricide treatment group: fenpyroximate-selected (green), pyridaben-selected (blue), 1163 
and tebufenpyrad-selected (gray). The orientation of gene models is as indicated (“+” or “-” 1164 
for forward and reverse strands, respectively). Coding exons are denoted by rectangles shaded 1165 
in light gray, and introns are shaded in darker gray. Putative candidate genes at the BSA peaks 1166 
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are highlighted in orange (the June 2016 T. urticae annotation, Online Resource for 1167 
Community Annotation of Eukaryotes, or ORCAE, was used). The candidate genes are: (A) 1168 
QTL 1 (all selections); target enzyme NADH: ubiquinone oxidoreductase (PSST; 1169 
tetur07g05240), (B) QTL 2 (pyridaben and tebufenpyrad selections); cytochrome P450-1170 
reductase (CPR) (tetur18g03390), and (C) QTL 3 (tebufenpyrad selections only); nuclear 1171 
hormone receptor 96 (NHR96)-like DNA-binding domain (DBD)-lacking (tetu06g04270).  1172 
 1173 
Fig. 5. Alignment of cytochrome P450 reductase (CPR) sequences around the D384Y variant. 1174 
The conservation of alpha helices H (left), I (middle) and J (right) is shown. An 80% 1175 
threshold was used for identity (black background) and similarity shading (gray background). 1176 
The D384Y variant is located at the end of helix I (red star). The residue is charged in 1177 
arthropods (D in the scorpion C. sculpturatus and the spider mite and E in the insects M. 1178 
domestica and D. melanogaster), while most vertebrates have a polar Q at that position. The 1179 
homologous Q391 in the human CPR is predicted to interact with the FMN domain in the 1180 
open conformation in which electron transfer to P450s occurs. 1181 
 1182 
Fig. 6. Phylogenetic analysis of T. urticae nuclear hormone receptor (NHR) genes, and 1183 
genomic distribution of T. urticae DBD-lacking NHR96-like genes. (A) Maximum likelihood 1184 
LG + G phylogenetic tree of NHRs in D. melanogaster, D. pulex and T. urticae. Only 1185 
bootstrapping values higher than 65 are shown. The scale bar represents 0.5 amino acid 1186 
substitutions per site. Both T. urticae-specific DBD-lacking NHR96-like and canonical 1187 
NHR96-like gene expansions are shaded. (B) Genomic distribution of T. urticae's DBD-1188 
lacking NHR96-like genes is shown with lengths of vertical line segments corresponding to 1189 
the number of genes clustered (i.e., within 50kb of another such gene) in a head-to-tail 1190 
orientation. The orientation was delineated by “+” and “-” along the y-axis and by plotting the 1191 
bars in shades of orange and blue, respectively. Only intact DBD-lacking NHR96-like genes 1192 
were included in the analysis. The chromosomes are indicated by alternating white and gray 1193 
shading, while small scaffolds were concatenated and shaded in red to the right of the 1194 
chromosomes. 1195 
 1196 
Table 1197 
Table 1. Results of toxicity bioassays for the inbred parental strains MR-VP and Wasatch. 1198 
Strain MR-VP showed significantly higher levels of resistance compared to strain Wasatch 1199 
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for every acaricide tested. METI-I resistance of MR-VP had also been determined prior to the 1200 
strain’s inbreeding by Van Pottelberge et al. (2009b). 1201 
 1202 
 Inbred Wasatch LC50  
(mg a.i. L-1, 95% CI) 
Inbred MR-VP LC50  
(mg a.i. L-1, 95% CI) 
Resistance 
factor 
MR-VP before inbreeding LC50 
(mg a.i. L-1, 95% CI) 
Fenpyroximate 26.357  
(18.161 – 32.101) 
> 5000  > 190 10581 
(8441-13036) 
Pyridaben 4.274  
(3.759 – 4.845) 
2275.72  
(1944.83 – 2663.03) 
532 36959 
(26450-59590) 
Tebufenpyrad 5.722  
(4.788 – 6.818) 
416.932  
(356.990 – 475.636) 
73 1197 
(1080-1309) 
 1203 
Supplementary Figures  1204 
Fig. S1. Principal component analysis (PCA) with control and selected populations based on 1205 
genome-wide allele frequencies at polymorphic sites. Individual populations are colored 1206 
according to the treatment group (legend, upper right). The extreme outlier in the pyridaben-1207 
selected group (population P9) had the genomic profile of an unknown strain not used in this 1208 
study and was presumed to be contaminated. Hence, P9 was excluded from subsequent 1209 
analyses. 1210 
 1211 
Fig. S2. Fraction of heterozygous SNPs plotted across the genome in sliding windows of 1212 
150kb with a 10kb offset. Shown is apparent heterozygosity for the outbred strain MAR-AB, 1213 
a strain that was mother-son (MS) inbred for one generation (Albino-JP) and two strains that 1214 
were inbred for 6 or more generations (MR-VP and Wasatch).  1215 
 1216 
Fig. S3. MR-VP allele frequency and average window distance (AWD) values calculated as 1217 
per Wybouw et al. (2019). Each panel (A-C) corresponds to an individual acaricide selection 1218 
experiment and consists of MR-VP allele frequency information for each relevant sample 1219 
(top) and the AWD values (bottom) calculated based on the allele frequency information. The 1220 
samples were colored according to the experimental treatment (legend in the top right corner). 1221 
The AWD values were used to verify the three-chromosome assembly of Wybouw et al. 1222 
(2019), with the dashed line representing an AWD value of 0.1 – a threshold indicative of 1223 
potential misassemblies. One common AWD peak in the fenpyroximate, pyridaben and 1224 
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tebufenpyrad data rises above the threshold (highlighted in red in the bottom panels). The 1225 
AWD peak, however, was not supported as a misassembly in previous work. Overall, the 1226 
AWD scan provides strong support for the three-chromosome assembly. The peaks in AWD 1227 
values between the three chromosomes in the concatenated sequence are expected as they are 1228 
not adjacent in the genome. 1229 
 1230 
Fig. S4 Read coverage of five MR-VP RNA-seq replicates that were aligned to a modified 1231 
version of the three-chromosome assembly. The modified sequence contained an MR-VP de 1232 
novo assembled contig in the region where tetur06g04270 duplication was present in both 1233 
strains MR-VP and Wasatch. The plot zooms in on the part of the contig where the two NHR-1234 
like genes are located in tandem. Genetic architecture is shown in the bottom panel with taller 1235 
rectangles as coding exons, smaller rectangles as introns, “M”s as start codons, and stop 1236 
codons as asterisks. 1237 
Supplementary Tables  1238 
Table S1. Accession numbers used for maximum likelihood phylogenetic analysis of nuclear 1239 
receptors. 1240 
 1241 
Table S2. List of all genes in the 80kb top BSA peak 1 region at ~30Mb on Chr1. 1242 
 1243 
Table S3. List of all genes in the 75kb top BSA peak 2 region at ~5.7Mb on Chr2. 1244 
 1245 
Table S4. List of all genes in the 75kb top BSA peak 3 region at ~12.5Mb on Chr1. 1246 
 1247 
Supplementary Files 1248 
File S1. De novo assembled contigs of strains MR-VP and Wasatch that span the DNA-binding 1249 
domain (DBD)-lacking nuclear hormone receptor 96 (NHR96) like gene (tetur06g04270) in 1250 
the QTL underlying resistance to tebufenpyrad. 1251 
 1252 
File S2. Peptide sequences of tandemly duplicated DBD-lacking NHR96-like genes (annotated 1253 
as a single gene, tetur06g04270, in the London reference genome) in strains MR-VP and 1254 
Wasatch, as verified by open reading frame (ORF) predictions as well as RNA-seq alignments. 1255 
 1256 
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File S3. Genes newly annotated as DBD-lacking NHR96-like in the London assembly of T. 1257 
urticae. 1258 
